Publications

ANGPTL2 activity in cardiac pathologies accelerates heart failure by perturbing cardiac function and energy metabolism. 

Zhe Tian, Keishi Miyata, Tsuyoshi Kadomatsu, Haruki Horiguchi, Hiroyuki Fukushima, Shugo Tohyama, Yoshihiro Ujihara, Takahiro Okumura, Satoshi Yamaguchi, Jiabin Zhao, Motoyoshi Endo, Jun Morinaga, Michio Sato, Taichi Sugizaki, Shunshun Zhu, Kazutoyo Terada, Hisashi Sakaguchi, Yoshihiro Komohara, Motohiro Takeya, Naoki Takeda, Kimi Araki, Ichiro Manabe, Keiichi Fukuda, Kinya Otsu, Jun Wada, Toyoaki Murohara, Satoshi Mohri, Jun K Yamashita, Motoaki Sano, Yuichi Oike

Nature communications 7 13016-13016, 28 September 2016

H1foo Has a Pivotal Role in Qualifying Induced Pluripotent Stem Cells. 

Akira Kunitomi, Shinsuke Yuasa, Fumihiro Sugiyama, Yuki Saito, Tomohisa Seki, Dai Kusumoto, Shin Kashimura, Makoto Takei, Shugo Tohyama, Hisayuki Hashimoto, Toru Egashira, Yoko Tanimoto, Saori Mizuno, Shoma Tanaka, Hironobu Okuno, Kazuki Yamazawa, Hideo Watanabe, Mayumi Oda, Ruri Kaneda, Yumi Matsuzaki, Toshihiro Nagai, Hideyuki Okano, Ken-Ichi Yagami, Mamoru Tanaka, Keiichi Fukuda

Stem cell reports 6(6) 825-833, 14 June 2016

Glutamine Oxidation Is Indispensable for Survival of Human Pluripotent Stem Cells. 

Shugo Tohyama, Jun Fujita, Takako Hishiki, Tomomi Matsuura, Fumiyuki Hattori, Rei Ohno, Hideaki Kanazawa, Tomohisa Seki, Kazuaki Nakajima, Yoshikazu Kishino, Marina Okada, Akinori Hirano, Takuya Kuroda, Satoshi Yasuda, Yoji Sato, Shinsuke Yuasa, Motoaki Sano, Makoto Suematsu, Keiichi Fukuda

Cell Metabolism 23(4) 663-74, 12 April 2016

PRESS RELEASE

Patient-Specific Induced Pluripotent Stem Cell Models: Characterization of iPS Cell-Derived Cardiomyocytes. 

Toru Egashira, Shinsuke Yuasa, Shugo Tohyama, Yusuke Kuroda, Tomoyuki Suzuki, Tomohisa Seki, Keiichi Fukuda

Methods in molecular biology (Clifton, N.J.) 1353 343-53, 2016

Future Treatment of Heart Failure Using Human iPSC-Derived Cardiomyocytes 

Shugo Tohyama, Keiichi Fukuda

Etiology and Morphogenesis of Congenital Heart Disease 25-31, 2016

ヒト多能性幹細胞におけるグルタミン代謝の役割と再生医療への応用 

遠山 周吾, 福田 恵一

月刊臨床免疫・アレルギー科 66(6) 627‐632-632, 25 December 2016

ヒト多能性幹細胞におけるグルタミン代謝の役割と再生医療への応用

遠山 周吾, 福田 恵一

臨床免疫・アレルギー科 66(6) 627-632, December 2016

20年後の再生医療を予測する 循環器領域へのiPS細胞の臨床応用の現状

福田 恵一, 遠山 周吾, 関 倫久, 湯浅 慎介, 藤田 淳

循環器専門医 24(2) 242-251, August 2016

iPS細胞を用いた循環器領域の再生医療

福田 恵一, 遠山 周吾, 関 倫久, 湯浅 慎介, 下地 顕一郎, 藤田 淳

日本内科学会雑誌 105(7) 1287‐1295, 10 July 2016

ヒト多能性幹細胞におけるグルタミン代謝を利用した心臓再生医療

遠山 周吾, 藤田 淳, 菱木 貴子, 末松 誠, 福田 恵一

日本分子生物学会年会プログラム・要旨集(Web) 39th, 2016